Skip to main content
Top

12-03-2024 | Sectio Caesarea | Case Report

Pregnancy-associated fulminant type 1 diabetes: a case report and review of the literature

Authors: Hikari Nebashi, Hitoshi Matsui, Chika Tei, Masanori Hasebe, Hiroko Takanashi

Published in: Diabetology International

Login to get access

Abstract

Pregnancy-associated fulminant type 1 diabetes (PF) has received high clinical attention because of its low incidence and poor prognosis. It poses a great threat to the lives of mothers and infants; therefore, it is imperative to understand its characteristics and approach methods. However, no studies have described whether a cesarean section or conservative treatment should be considered at the onset of PF. We report a case of PF, review the published literature and consider a cesarean section at the onset of PF. A 39-year-old woman was admitted to our hospital with dyspnea and nausea. The patient was diagnosed with PF. Insulin Lispro and Glargine were administered to control the blood glucose levels. Six hours later, the fetus died. The fetal status due to PF probably worsened during the conservative treatment. No perioperative complications have been reported for cesarean sections under diabetic ketoacidosis due to PF and there have been cases of live birth by emergency cesarean section. Identifying the features of PF and considering and performing cesarean sections early after diagnosis is essential to save fetal life.
Literature
1.
go back to reference Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y, Osaka IDDM Study Group. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med. 2000;342:301–7.CrossRefPubMed Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y, Osaka IDDM Study Group. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med. 2000;342:301–7.CrossRefPubMed
2.
go back to reference Imagawa A, Hanafusa T, Awata T, Ikegami H, Uchigata Y, Osawa H, et al. Report of the committee of the japan diabetes society on the Research of Fulminant and Acute-onset type 1 diabetes mellitus: new diagnostic criteria of fulminant type 1 diabetes mellitus (2012). J Diabetes Investig. 2012;3:536–9.CrossRefPubMedPubMedCentral Imagawa A, Hanafusa T, Awata T, Ikegami H, Uchigata Y, Osawa H, et al. Report of the committee of the japan diabetes society on the Research of Fulminant and Acute-onset type 1 diabetes mellitus: new diagnostic criteria of fulminant type 1 diabetes mellitus (2012). J Diabetes Investig. 2012;3:536–9.CrossRefPubMedPubMedCentral
3.
go back to reference Imagawa A, Hanafusa T, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, et al. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care. 2003;26:2345–52.CrossRefPubMed Imagawa A, Hanafusa T, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, et al. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care. 2003;26:2345–52.CrossRefPubMed
4.
go back to reference Shimizu I, Makino H, Osawa H, Kounoue E, Imagawa A, Hanafusa T, et al. Association of fulminant type 1 diabetes with pregnancy. Diab Res Clin Pract. 2003;62:33–8.CrossRef Shimizu I, Makino H, Osawa H, Kounoue E, Imagawa A, Hanafusa T, et al. Association of fulminant type 1 diabetes with pregnancy. Diab Res Clin Pract. 2003;62:33–8.CrossRef
5.
go back to reference Shimizu I, Makino H, Imagawa A, Iwahashi H, Uchigata Y, Kanatsuka A, et al. Clinical and immunogenetic characteristics of fulminant type 1 diabetes associated with pregnancy. J Clin Endocrinol Metab. 2006;91:471–6.CrossRefPubMed Shimizu I, Makino H, Imagawa A, Iwahashi H, Uchigata Y, Kanatsuka A, et al. Clinical and immunogenetic characteristics of fulminant type 1 diabetes associated with pregnancy. J Clin Endocrinol Metab. 2006;91:471–6.CrossRefPubMed
6.
go back to reference Michelle R, Nicholas CS, Haim AA. Diabetic ketoacidosis among pregnant and nonpregnant women: a comparison of morbidity and mortality. J Matern Fetal Neonatal Med. 2019;32:2649–52.CrossRef Michelle R, Nicholas CS, Haim AA. Diabetic ketoacidosis among pregnant and nonpregnant women: a comparison of morbidity and mortality. J Matern Fetal Neonatal Med. 2019;32:2649–52.CrossRef
7.
go back to reference Yumiko K, Nao N, Takuya A, Eiji K, Akihisa I, et al. Genome-wide association study confirming a strong effect of HLA and identifying variants in CSAD/lnc-ITGB7–1 on chromosome 12q1313 associated with susceptibility to fulminant type 1 diabetes. Diabetes. 2019;68:665–75.CrossRef Yumiko K, Nao N, Takuya A, Eiji K, Akihisa I, et al. Genome-wide association study confirming a strong effect of HLA and identifying variants in CSAD/lnc-ITGB7–1 on chromosome 12q1313 associated with susceptibility to fulminant type 1 diabetes. Diabetes. 2019;68:665–75.CrossRef
8.
go back to reference Yamamoto N, Fujita Y, Satoh S, Nakanami N, Sonoda N, Nakano H. Fulminant type 1 diabetes during pregnancy: a case report and review of the literature. J Obstet Gynaecol Res. 2007;33:552–6.CrossRefPubMed Yamamoto N, Fujita Y, Satoh S, Nakanami N, Sonoda N, Nakano H. Fulminant type 1 diabetes during pregnancy: a case report and review of the literature. J Obstet Gynaecol Res. 2007;33:552–6.CrossRefPubMed
9.
go back to reference Liu L, Jia W, Liu R, Shen J. Clinical study of pregnancy-associated fulminant type 1 diabetes. Endocrine. 2018;60:301–7.CrossRefPubMed Liu L, Jia W, Liu R, Shen J. Clinical study of pregnancy-associated fulminant type 1 diabetes. Endocrine. 2018;60:301–7.CrossRefPubMed
10.
go back to reference Murabayashi N, Sugiyama T, Kihira C, Kusaka H, Sugihara T, Sagawa N. A case of fulminant type 1 diabetes mellitus associated with pregnancy. J Obstet Gynaecol Res. 2009;35:1121–4.CrossRefPubMed Murabayashi N, Sugiyama T, Kihira C, Kusaka H, Sugihara T, Sagawa N. A case of fulminant type 1 diabetes mellitus associated with pregnancy. J Obstet Gynaecol Res. 2009;35:1121–4.CrossRefPubMed
11.
go back to reference Tanoshima M, Mihara T, Ogawa M, Okuda M, Takahashi T, Hirahara F. Two cases of non-autoimmune, Fulminant Type 1 Diabetes presenting with diabetic ketoacidosis during pregnancy. J Jpn Soc Perin Neon Med. 2009;45:156–60 ((in Japanese)). Tanoshima M, Mihara T, Ogawa M, Okuda M, Takahashi T, Hirahara F. Two cases of non-autoimmune, Fulminant Type 1 Diabetes presenting with diabetic ketoacidosis during pregnancy. J Jpn Soc Perin Neon Med. 2009;45:156–60 ((in Japanese)).
12.
go back to reference Yamada K, Takakuwa K, Takeyama S, Minagawa S, Morikawa H, Matsunaga M, et al. Fulminant type 1 diabetes mellitus acutely emerged during pregnancy. J Obstet Gynaecol Res. 2010;36:424–7.CrossRefPubMed Yamada K, Takakuwa K, Takeyama S, Minagawa S, Morikawa H, Matsunaga M, et al. Fulminant type 1 diabetes mellitus acutely emerged during pregnancy. J Obstet Gynaecol Res. 2010;36:424–7.CrossRefPubMed
13.
go back to reference Fukuda T, Kusaka T, Toyama MMY. Acase of fulminant type l diabetes with pregnancy diagnosed by decreased fetal movement. J Jpn Soc Perin Neon Med. 2013;49:1276–80 ((in Japanese)). Fukuda T, Kusaka T, Toyama MMY. Acase of fulminant type l diabetes with pregnancy diagnosed by decreased fetal movement. J Jpn Soc Perin Neon Med. 2013;49:1276–80 ((in Japanese)).
14.
go back to reference Harada Y, Umino W, Takase K, Nagaoka K, Karasawa S, Wada K, et al. A case of fulminant type 1 diabetes mellitus associated with pregnancy having safely given birth by emergency Caesarean section. J Jpn Diab Soc. 2020;63:50–5 ((in Japanese)). Harada Y, Umino W, Takase K, Nagaoka K, Karasawa S, Wada K, et al. A case of fulminant type 1 diabetes mellitus associated with pregnancy having safely given birth by emergency Caesarean section. J Jpn Diab Soc. 2020;63:50–5 ((in Japanese)).
15.
go back to reference Ichikawa T, Kitae A, Takeda S, Sueyoshi A, Hamaguchi M, Fukui M. Transition of blood glucose level in a patient with pregnancy-associated fulminant type 1 diabetes mellitus. J Diabetes Investig. 2021;12:894–6.CrossRefPubMed Ichikawa T, Kitae A, Takeda S, Sueyoshi A, Hamaguchi M, Fukui M. Transition of blood glucose level in a patient with pregnancy-associated fulminant type 1 diabetes mellitus. J Diabetes Investig. 2021;12:894–6.CrossRefPubMed
16.
go back to reference Fujita S, Hayashi S, Uchishiba M, Imai H, Nakagawa Y. A case of fulminant type 1 diabetes associated with pregnancy. Mod Trends Obstet Gynecol. 2016;65:171–6 ((in Japanese)). Fujita S, Hayashi S, Uchishiba M, Imai H, Nakagawa Y. A case of fulminant type 1 diabetes associated with pregnancy. Mod Trends Obstet Gynecol. 2016;65:171–6 ((in Japanese)).
17.
go back to reference Iimura N, Kishimoto R, Kido K, Higa T, Namai S, Teshima E, et al. A case of pregnancy associated fulminant Type l Diabetes Mellitus found by metabolic ketoacidosis, which brought neonatal death. J Jpn Soc Study Womens Nutr Metab. 2017;23:85–6 ((in Japanese)). Iimura N, Kishimoto R, Kido K, Higa T, Namai S, Teshima E, et al. A case of pregnancy associated fulminant Type l Diabetes Mellitus found by metabolic ketoacidosis, which brought neonatal death. J Jpn Soc Study Womens Nutr Metab. 2017;23:85–6 ((in Japanese)).
18.
go back to reference Hayakawa T, Nakano Y, Hayakawa K, Yoshimatu H, Hori Y, Yamanishi K, et al. Fulminant type 1 diabetes mellitus associated with coxsackievirus type B1 infection during pregnancy: a case report. J Med Case Rep. 2019;13:186.CrossRefPubMedPubMedCentral Hayakawa T, Nakano Y, Hayakawa K, Yoshimatu H, Hori Y, Yamanishi K, et al. Fulminant type 1 diabetes mellitus associated with coxsackievirus type B1 infection during pregnancy: a case report. J Med Case Rep. 2019;13:186.CrossRefPubMedPubMedCentral
19.
go back to reference Ogawa A, Okuno M, Takeuchi K, Takekida S. Fulminant type1 diabetes associated with pregnancy: a report of two cases. Adv Obstet Gynecol. 2022;74:338–42 ((in Japanese)). Ogawa A, Okuno M, Takeuchi K, Takekida S. Fulminant type1 diabetes associated with pregnancy: a report of two cases. Adv Obstet Gynecol. 2022;74:338–42 ((in Japanese)).
20.
go back to reference Zhou L, Qu H, Zhang Q, Hu J, Shou L. Case report: fulminant type 1 diabetes following paucisymptomatic SARS-CoV-2 infection during late pregnancy. Front Endocrinol (Lausanne). 2023;14:1168927.CrossRefPubMed Zhou L, Qu H, Zhang Q, Hu J, Shou L. Case report: fulminant type 1 diabetes following paucisymptomatic SARS-CoV-2 infection during late pregnancy. Front Endocrinol (Lausanne). 2023;14:1168927.CrossRefPubMed
21.
go back to reference Kimijima T, Masuda Y, Imaizumi H, Tatsumi H, Goto K, Kyan R, et al. A case of fulminant type 1 diabetes associated with pregnancy. J Jpn Soc Intensive Care Med. 2015;22:273–4 ((in Japanese)).CrossRef Kimijima T, Masuda Y, Imaizumi H, Tatsumi H, Goto K, Kyan R, et al. A case of fulminant type 1 diabetes associated with pregnancy. J Jpn Soc Intensive Care Med. 2015;22:273–4 ((in Japanese)).CrossRef
22.
go back to reference Fujibe Y, Negishi H, Iizaka T, Iwabuchi A, Mizunuma M. A Case of Fulminant Type l Diabetes Mellitus Acquired at 21 weeks of Gestation and successful procreation. J Hokkaido Obstet Gynecol Soc. 2016;60:11–6 ((in Japanese)). Fujibe Y, Negishi H, Iizaka T, Iwabuchi A, Mizunuma M. A Case of Fulminant Type l Diabetes Mellitus Acquired at 21 weeks of Gestation and successful procreation. J Hokkaido Obstet Gynecol Soc. 2016;60:11–6 ((in Japanese)).
23.
go back to reference Komiya T, Yamaoka K, Namai K, Ban M. A case of fulminant type 1 diabetes mellitus developed in late pregnancy and achieved successful delivery. J Jpn Diab Soc. 2019;62:155–61 ((in Japanese)). Komiya T, Yamaoka K, Namai K, Ban M. A case of fulminant type 1 diabetes mellitus developed in late pregnancy and achieved successful delivery. J Jpn Diab Soc. 2019;62:155–61 ((in Japanese)).
24.
go back to reference Kay HAC, Tang W, Rena HMC, Jeff RF. Fulminant type 1 diabetes mellitus in a GDM pregnancy: early recognition is vital for maternal and fetal outcomes. Endocrinol Diabetes Metab Case Rep. 2022;2022:22–0262. Kay HAC, Tang W, Rena HMC, Jeff RF. Fulminant type 1 diabetes mellitus in a GDM pregnancy: early recognition is vital for maternal and fetal outcomes. Endocrinol Diabetes Metab Case Rep. 2022;2022:22–0262.
25.
go back to reference Otsubo M, Shiozawa T, Kimura K, Konishi I. Nonimmune, “Fulminant” type 1 diabetes presenting with diabetic ketoacidosis during pregnancy. Obstet Gynecol. 2002;99:877–9.PubMed Otsubo M, Shiozawa T, Kimura K, Konishi I. Nonimmune, “Fulminant” type 1 diabetes presenting with diabetic ketoacidosis during pregnancy. Obstet Gynecol. 2002;99:877–9.PubMed
27.
go back to reference Caughey AB, Cahill AG, Guise JM, Rouse DJ. Safe prevention of the primary cesarean delivery. Am J Obstet Gynecol. 2014;210:179–93.CrossRefPubMed Caughey AB, Cahill AG, Guise JM, Rouse DJ. Safe prevention of the primary cesarean delivery. Am J Obstet Gynecol. 2014;210:179–93.CrossRefPubMed
28.
go back to reference Dagogo-Jack S, Alberti KGMM. Management of diabetes mellitus in surgical patients. Diabetes Spectr. 2002;15(1):44–8.CrossRef Dagogo-Jack S, Alberti KGMM. Management of diabetes mellitus in surgical patients. Diabetes Spectr. 2002;15(1):44–8.CrossRef
29.
go back to reference Kavanagh BP, McCowen KC. Clinical practice. Glycemic control in the ICU. N Engl J Med. 2010;363:2540–6.CrossRefPubMed Kavanagh BP, McCowen KC. Clinical practice. Glycemic control in the ICU. N Engl J Med. 2010;363:2540–6.CrossRefPubMed
30.
go back to reference Ren-qi Y, Chao R, Guo-sheng W, Yi-bing Z, Zhao-fan X, et al. Is intensive glucose control bad for critically ill patients? A systematic review and meta-analysis. Int J Biol Sci. 2020;16:1658–75.CrossRef Ren-qi Y, Chao R, Guo-sheng W, Yi-bing Z, Zhao-fan X, et al. Is intensive glucose control bad for critically ill patients? A systematic review and meta-analysis. Int J Biol Sci. 2020;16:1658–75.CrossRef
Metadata
Title
Pregnancy-associated fulminant type 1 diabetes: a case report and review of the literature
Authors
Hikari Nebashi
Hitoshi Matsui
Chika Tei
Masanori Hasebe
Hiroko Takanashi
Publication date
12-03-2024
Publisher
Springer Nature Singapore
Published in
Diabetology International
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-024-00706-9
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.